Kreon

Pancreatin, the active ingredient in Kreon, is a pancreatic enzyme replacement therapy presented as an enteric‑coated capsule for oral use. It supplies the digestive enzymes amylase, lipase and protease to patients with exocrine pancreatic insufficiency caused by cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after pancreatic resection, helping to improve nutrient digestion.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality, regulatory compliance and reliable logistics for global healthcare providers.

Kreon is indicated for conditions involving exocrine pancreatic insufficiency, where it supplements deficient digestive enzymes.

- Cystic fibrosis: improves digestion and nutrient absorption by providing pancreatic enzymes. - Chronic pancreatitis: reduces steatorrhea and abdominal discomfort associated with malabsorption. - Pancreatic cancer: supports digestive function when tumor involvement impairs pancreatic secretion. - Post‑pancreatic resection: aids in the breakdown of fats, proteins and carbohydrates after surgical loss of pancreatic tissue.

Kreon may cause adverse reactions related to its enzyme content or capsule formulation.

Common Side Effects: - Abdominal discomfort: mild cramping or pain after meals - Flatulence: increased gas production and bloating - Oily or fatty stools: steatorrhea due to unabsorbed fat - Nausea: feeling of sickness without vomiting - Constipation: reduced bowel movements and hard stools - Diarrhea: loose, watery stools

Serious or Rare Side Effects: - Allergic reactions: rash, urticaria or anaphylaxis requiring immediate care - Severe abdominal pain: intense pain that may indicate obstruction - Intestinal obstruction: blockage of the intestinal tract - Fecal incontinence: loss of control over bowel movements - Pancreatitis exacerbation: worsening of pancreatic inflammation

Before prescribing Kreon, healthcare professionals should consider the following precautions.

- Assess enzyme deficiency: evaluate stool fat content and clinical symptoms before initiating therapy. - Adjust dose individually: titrate based on nutritional status, weight and response. - Monitor for hypersensitivity: watch for signs of allergic reaction, especially in patients with porcine protein sensitivity. - Use with meals and snacks: take capsules at the start of each main meal for optimal enzyme activation. - Avoid concomitant use of antacids containing aluminum or magnesium: they may reduce enzyme efficacy. - Store at below 25°C: keep in the original container, protect from moisture and heat.

Kreon can interact with certain medicines, affecting either its efficacy or the partner drug’s action.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may bind enzymes and lower digestive activity. - Orlistat: reduces fat absorption and can diminish the benefit of pancreatic enzymes. - High‑dose proton pump inhibitors: may alter capsule dissolution and enzyme release.

Moderate Interactions (Monitor Closely): - Warfarin: changes in vitamin K absorption could affect anticoagulation control. - Digoxin: altered intestinal absorption may modify serum levels. - Tetracycline antibiotics: may chelate with enzymes and reduce their activity.